Nuzenio

Definium Therapeutics

Definium Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 23:35:37 GMTDefinium Therapeutics (DFTX) Is Up 6.0% After Strong DT120 Data Amid Wider Q2 Net Loss - simplywall.st
Sat, 08 Aug 2026 06:43:13 GMTDefinium Therapeutics, Inc. (NASDAQ:DFTX) Receives Average Recommendation of "Buy" from Analysts - marketbeat.com
Fri, 07 Aug 2026 20:48:50 GMTDefinium Therapeutics (DFTX) Reports Strong Phase III Data, Is It Still Below Fair Value? - simplywall.st
Fri, 07 Aug 2026 08:29:32 GMTDefinium Therapeutics (DFTX) Boosts Cash Reserves Amid Psychedelic Medicine Advances - GuruFocus
Fri, 07 Aug 2026 08:04:00 GMTIs Definium Therapeutics Inc (DFTX) Facing Challenges After Repo - GuruFocus
Fri, 07 Aug 2026 05:10:00 GMTDefinium Therapeutics Inc (DFTX) (Q2 2026) Earnings Call Highlights: Record Phase III MDD ... - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Definium Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.